Andreas Hohn

Title: The Innovations of Andreas Hohn

Introduction

Andreas Hohn is a notable inventor based in Germany. He has made significant contributions to the field of neurotrophic factors, particularly in relation to brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3). His work focuses on the therapeutic applications of these proteins in treating neurological disorders.

Latest Patents

Andreas Hohn's latest patents include innovations related to BDNF. The first patent discusses nucleic acid sequences encoding BDNF, which can be produced in sufficient quantities for clinical use. This invention provides a method for promoting the survival of neurons, offering potential treatments for Parkinson's disease and Alzheimer's disease. The second patent introduces neurotrophin-3, a newly discovered member of the BDNF gene family. This invention highlights the potential of NT-3 in diagnosing and treating neurological disorders, providing new options for central nervous system repair.

Career Highlights

Throughout his career, Andreas Hohn has worked with prominent organizations such as Regeneron Pharmaceuticals, Inc. and the Max Planck Society for the Advancement of Science. His research has contributed to the understanding of neurotrophic factors and their applications in medicine.

Collaborations

Andreas has collaborated with notable colleagues, including Carolyn Hyman and Ralph Alderson. These partnerships have furthered his research and innovations in the field of neurobiology.

Conclusion

Andreas Hohn's work in neurotrophic factors has the potential to revolutionize treatments for neurological disorders. His contributions to the field are significant and continue to inspire future research and innovation.